Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$18.06
-3.5%
$19.30
$17.24
$30.28
$834.43M0.96277,314 shs52,561 shs
D8 Holdings Corp. stock logo
DEH
D8
$0.27
-3.5%
$11.31
$9.50
$11.66
$11.77MN/A380,936 shs177,642 shs
Eargo, Inc. stock logo
EAR
Eargo
$70.50
$52.85
$1.47
$8.48
$1.46B1.523,347 shsN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$48.58
-0.8%
$47.78
$16.96
$73.00
$1.33B1.24423,300 shs124,970 shs
Inogen, Inc. stock logo
INGN
Inogen
$6.57
-6.8%
$7.54
$4.13
$14.10
$154.72M1.06553,070 shs84,676 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-0.32%-0.05%-4.10%-4.79%-38.22%
D8 Holdings Corp. stock logo
DEH
D8
-3.77%-1.48%-18.51%-33.15%-87.71%
Eargo, Inc. stock logo
EAR
Eargo
0.00%0.00%0.00%+2,482.42%+1,374.90%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-1.49%-6.14%+2.49%+35.93%-32.01%
Inogen, Inc. stock logo
INGN
Inogen
+2.17%+1.44%-6.25%+25.00%-46.63%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
4.171 of 5 stars
3.34.00.00.03.93.32.5
D8 Holdings Corp. stock logo
DEH
D8
N/AN/AN/AN/AN/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/AN/AN/AN/AN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
0.7709 of 5 stars
2.50.00.00.02.52.50.6
Inogen, Inc. stock logo
INGN
Inogen
2.1218 of 5 stars
1.04.00.03.90.01.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.50
Moderate Buy$31.0065.78% Upside
D8 Holdings Corp. stock logo
DEH
D8
N/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
3.00
Buy$55.0012.36% Upside
Inogen, Inc. stock logo
INGN
Inogen
2.00
Hold$7.506.38% Upside

Current Analyst Ratings

Latest AVNS, ESTA, INGN, EAR, and DEH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2024
Inogen, Inc. stock logo
INGN
Inogen
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/3/2024
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$49.00 ➝ $60.00
4/1/2024
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $65.00
2/29/2024
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$46.00 ➝ $53.00
2/15/2024
Inogen, Inc. stock logo
INGN
Inogen
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$673.30M1.28$2.02 per share9.28$26.63 per share0.70
D8 Holdings Corp. stock logo
DEH
D8
N/AN/AN/AN/A$0.12 per shareN/A
Eargo, Inc. stock logo
EAR
Eargo
$41.11M35.61N/AN/A$4.87 per share14.48
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$165.15M8.14N/AN/A$0.71 per share68.94
Inogen, Inc. stock logo
INGN
Inogen
$315.66M0.53N/AN/A$8.79 per share0.80

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-$61.80M-$1.32N/A10.16N/A-8.76%4.25%3.11%5/1/2024 (Estimated)
D8 Holdings Corp. stock logo
DEH
D8
-$9.46MN/A0.00N/AN/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
-$157.49M-$7.52N/AN/A-263.14%-135.08%-96.37%N/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$78.50M-$3.04N/AN/AN/A-47.53%-357.81%-30.37%5/13/2024 (Estimated)
Inogen, Inc. stock logo
INGN
Inogen
-$102.45M-$4.41N/AN/AN/A-32.46%-38.98%-27.03%5/7/2024 (Confirmed)

Latest AVNS, ESTA, INGN, EAR, and DEH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Inogen, Inc. stock logo
INGN
Inogen
-$0.76N/A+$0.76N/AN/AN/A  
4/25/2024N/A
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/A$0.21+$0.21N/AN/AN/A
2/28/2024Q4 2023
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.95-$0.79+$0.16-$0.79$31.44 million$31.60 million      
2/27/2024Q4 2023
Inogen, Inc. stock logo
INGN
Inogen
-$0.65-$1.14-$0.49-$1.14$78.09 million$75.90 million
2/20/202412/31/2023
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.37$0.36-$0.01$0.49$170.43 million$173.30 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/AN/AN/AN/AN/A
D8 Holdings Corp. stock logo
DEH
D8
N/AN/AN/AN/AN/A
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/AN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
Inogen, Inc. stock logo
INGN
Inogen
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.13
2.08
1.38
D8 Holdings Corp. stock logo
DEH
D8
N/A
0.13
0.13
Eargo, Inc. stock logo
EAR
Eargo
N/A
3.22
2.97
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
10.26
3.06
1.67
Inogen, Inc. stock logo
INGN
Inogen
N/A
2.86
2.55

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
95.17%
D8 Holdings Corp. stock logo
DEH
D8
65.44%
Eargo, Inc. stock logo
EAR
Eargo
80.53%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
Inogen, Inc. stock logo
INGN
Inogen
89.94%

Insider Ownership

CompanyInsider Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.90%
D8 Holdings Corp. stock logo
DEH
D8
N/A
Eargo, Inc. stock logo
EAR
Eargo
0.81%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11.44%
Inogen, Inc. stock logo
INGN
Inogen
0.64%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
3,77146.20 million44.86 millionOptionable
D8 Holdings Corp. stock logo
DEH
D8
343.13 millionN/ANot Optionable
Eargo, Inc. stock logo
EAR
Eargo
24320.76 million20.59 millionNot Optionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
90827.46 million24.32 millionOptionable
Inogen, Inc. stock logo
INGN
Inogen
83423.55 million23.40 millionOptionable

ESTA, AVNS, INGN, EAR, and DEH Headlines

SourceHeadline
Inogen, Inc. (NASDAQ:INGN) Short Interest Down 9.6% in MarchInogen, Inc. (NASDAQ:INGN) Short Interest Down 9.6% in March
americanbankingnews.com - April 16 at 5:34 AM
Inogen, Inc. (NASDAQ:INGN) Short Interest UpdateInogen, Inc. (NASDAQ:INGN) Short Interest Update
marketbeat.com - April 15 at 10:35 AM
Inogen: New Management And A Major Competitor Exit Offer Some New OpportunitiesInogen: New Management And A Major Competitor Exit Offer Some New Opportunities
seekingalpha.com - April 13 at 6:03 AM
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
businesswire.com - April 10 at 8:30 AM
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Inogen (INGN) and Galectin Therapeutics (GALT)Analysts’ Opinions Are Mixed on These Healthcare Stocks: Inogen (INGN) and Galectin Therapeutics (GALT)
markets.businessinsider.com - April 9 at 7:35 PM
Inogens (INGN) "Hold" Rating Reaffirmed at Needham & Company LLCInogen's (INGN) "Hold" Rating Reaffirmed at Needham & Company LLC
marketbeat.com - April 9 at 12:12 PM
Inogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue?Inogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue?
zacks.com - March 28 at 12:36 PM
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
zacks.com - March 28 at 12:31 PM
Inogen To Present at 23rd Annual Needham Virtual Healthcare ConferenceInogen To Present at 23rd Annual Needham Virtual Healthcare Conference
businesswire.com - March 25 at 8:30 AM
INGN Apr 2024 10.000 callINGN Apr 2024 10.000 call
ca.finance.yahoo.com - March 18 at 4:51 PM
INGN Apr 2024 5.000 putINGN Apr 2024 5.000 put
finance.yahoo.com - March 17 at 11:25 PM
INGN Apr 2024 15.000 callINGN Apr 2024 15.000 call
finance.yahoo.com - March 17 at 1:42 AM
INGN Apr 2024 12.500 callINGN Apr 2024 12.500 call
finance.yahoo.com - March 16 at 3:10 PM
INGN Apr 2024 7.500 putINGN Apr 2024 7.500 put
finance.yahoo.com - March 16 at 3:10 PM
Inogen Alliance: Preparing for 4 New EU Environmental Regulations in 2024Inogen Alliance: Preparing for 4 New EU Environmental Regulations in 2024
finanznachrichten.de - March 13 at 8:51 PM
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
businesswire.com - March 7 at 4:00 PM
Inogen Full Year 2023 Earnings: EPS Misses ExpectationsInogen Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - March 1 at 9:59 AM
Inogen, Inc. (NASDAQ:INGN) Q4 2023 Earnings Call TranscriptInogen, Inc. (NASDAQ:INGN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 29 at 9:05 AM
Inogen Inc.Inogen Inc.
barrons.com - February 29 at 1:09 AM
Why Is Inogen Stock Plummeting Today?Why Is Inogen Stock Plummeting Today?
msn.com - February 28 at 3:06 PM
Inogen (INGN) Q4 Earnings Miss Estimates, Gross Margin ImprovesInogen (INGN) Q4 Earnings Miss Estimates, Gross Margin Improves
zacks.com - February 28 at 10:26 AM
Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesInogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - February 27 at 8:31 PM
Inogen (INGN) Reports Q4 Loss, Misses Revenue EstimatesInogen (INGN) Reports Q4 Loss, Misses Revenue Estimates
zacks.com - February 27 at 7:26 PM
Inogen: Q4 Earnings SnapshotInogen: Q4 Earnings Snapshot
timesunion.com - February 27 at 7:05 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Avanos Medical logo

Avanos Medical

NYSE:AVNS
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
D8 logo

D8

NYSE:DEH
D8 Holdings Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Central, Hong Kong.
Eargo logo

Eargo

NASDAQ:EAR
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
Establishment Labs logo

Establishment Labs

NASDAQ:ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Inogen logo

Inogen

NASDAQ:INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.